At a glance
ClinicalIndex Comparison RecordPhase 2Completed· 22 enrolled
Drug / intervention
Milk Thistle +1 moredrug
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.
Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.
Silymarin Treatment of Trichotillomania in Children and Adults: A Double-Blind, Placebo-Controlled, Cross-Over Study
In Brief
A Phase 2 clinical trial evaluating Milk Thistle and Placebo for Trichotillomania and Hair Pulling Disorder. Completed, enrolled 22 participants across 1 site.
Detailed Summary
The goal of the proposed study is to evaluate the efficacy and safety of silymarin (milk thistle) in children and adults with trichotillomania. The hypothesis to be tested is that silymarin will be more effective and well tolerated in children and adults with trichotillomania compared to placebo. The proposed study will provide needed data on the treatment of a disabling disorder that currently lacks a clearly effective treatment.
Study Details
Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsTrichotillomania, Hair Pulling Disorder
CountriesUnited States
Collaborators--
Timeline
Phase 2CompletedFinished
201520162017201820192020202120222023202420252026
Enrollment StartMar 2015
First PostedJun 2015
Primary CompletionJun 2018
Study CompletionSep 2020
TodayJul 2026
First PostedJun 17, 2015
Enrollment StartMar 1, 2015
Primary CompletionJun 1, 2018
Study CompletionSep 1, 2020
TodayJul 1, 2026
Enrollment to primary: 3.3 yearsPosted 11.0 years ago
Interventions
Milk Thistledrug
Placebodrug